Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Classical hematology 5Gastrointestinal 3Thoracic 2Plasma cell 1Myeloid 1Lymphoid 1Breast 1

Conditions

Multiple Myeloma 935Lymphoma 113Neoplasms, Plasma Cell 92Recurrence 91Lymphoma, Non-Hodgkin 68Hematologic Neoplasms 60Immunoglobulin Light-chain Amyloidosis 57Neoplasms 54Smoldering Multiple Myeloma 52Leukemia, Myeloid, Acute 51Leukemia 51Myelodysplastic Syndromes 47Leukemia, Lymphocytic, Chronic, B-Cell 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Hodgkin Disease 38Leukemia, Plasma Cell 27Myeloproliferative Disorders 24Breast Neoplasms 24Lymphoma, Large B-Cell, Diffuse 23Monoclonal Gammopathy of Undetermined Significance 22Lymphoma, Mantle-Cell 22Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Amyloidosis 22Primary Myelofibrosis 21Lymphoma, Follicular 21Waldenstrom Macroglobulinemia 20Ovarian Neoplasms 20Lymphoma, B-Cell, Marginal Zone 17Lymphoma, B-Cell 17Colorectal Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Plasma cell × 1 year × Clear all
NCT07018271 2025-06-12

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

The First Affiliated Hospital of Soochow University

Phase NA Not yet recruiting
24 enrolled
Plasma cell

Multiple Myeloma, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡